Pacific Biosciences of California Inc.

PACB | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.46

+$0.10 (+7.35%)

Sep 22, 2026, 11:58 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-546.38M	-309.85M	-306.74M	-314.25M	-181.22M	29.4M
Depreciation & Amortization	386.41M	53.34M	32.69M	17.32M	11.59M	9.3M
Stock-Based Compensation	41.67M	n/a	n/a	78.61M	80.73M	17.53M
Other Working Capital	11.3M	-42.75M	-27.49M	-26.55M	34.24M	5.01M
Other Non-Cash Items	3.19M	91.24M	77.88M	9.08M	50.37M	-33.87M
Deferred Income Tax	-546K	-205K	-11.42M	n/a	-93.65M	-107K
Change in Working Capital	4.44M	-40.58M	-58.96M	-53.97M	21.01M	-2.76M
Operating Cash Flow	-111.21M	-206.06M	-266.55M	-263.21M	-111.18M	19.5M
Capital Expenditures	-2.71M	-6.19M	-8.84M	-16.93M	-5.93M	-1.04M
Cash Acquisitions	n/a	n/a	-102K	179K	-319.79M	n/a
Purchase of Investments	-216.91M	-498.64M	-756.57M	-442.79M	-988.05M	-373.28M
Sales Maturities Of Investments	340.07M	628.83M	770.12M	575.8M	635.24M	155M
Other Investing Acitivies	-5M	n/a	n/a	-179K	n/a	n/a
Investing Cash Flow	115.45M	124M	4.6M	116.08M	-678.53M	-219.32M
Debt Repayment	n/a	-50.69M	-1.84M	-1.61M	895.18M	-16M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-86.41M	n/a	-20.44M	80.36M
Financial Cash Flow	3.43M	-42.99M	116.27M	9.62M	1.17B	251.84M
Net Cash Flow	7.67M	-124.15M	-145.18M	-137.51M	379.87M	52.02M
Free Cash Flow	-113.92M	-212.25M	-275.39M	-280.14M	-117.11M	18.46M
Adj. Free Cash Flow	-155.59M	-212.25M	-275.39M	-358.75M	-197.84M	931K
Maintenance CapEx	n/a	-6.19M	n/a	-16.93M	n/a	-1.04M
Growth CapEx	-2.71M	n/a	-8.84M	n/a	-5.93M	n/a
Owner Earnings	-111.21M	-212.25M	-266.55M	-280.14M	-111.18M	18.46M